JANE LEVY: Open Payments
NPI 1528459211 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,587 in 170 payments from 24 companies in 2025. Trend: 2023 $2,559 · 2024 $3,777 · 2025 $3,587
Food & beverage: $3,487Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $1,158 |
| ABBVIE INC. | 30 | $424 |
| GENZYME CORPORATION | 13 | $298 |
| Novartis Pharmaceuticals Corporation | 14 | $244 |
| Incyte Corporation | 18 | $216 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $167 |
| Galderma Laboratories, L.P. | 9 | $149 |
| Lilly USA, LLC | 9 | $141 |
| Organon LLC | 7 | $109 |
| UCB, Inc. | 3 | $106 |
Products named: TREMFYA, DUPIXENT, RINVOQ, OPZELURA, COSENTYX, SKYRIZI, NEMLUVIO, TALTZ.
Industry payments across PA — which companies pay providers there.
